Literature DB >> 16307872

Increased DNA damage in patients with chronic obstructive pulmonary disease who had once smoked or been exposed to biomass.

Erkan Ceylan1, Abdurrahim Kocyigit, Mehmet Gencer, Nurten Aksoy, Sahbettin Selek.   

Abstract

OBJECTIVE: Chronic obstructive pulmonary disease (COPD) is a slowly progressive condition characterised by poorly reversible airflow limitation associated with an abnormal inflammatory response of the lung. The main causal factors of COPD are chronic oxidative stress as a result of long-term smoking, use of biomass fuels, and air pollution. In this study, basal levels of DNA strand breaks were investigated together with some additional oxidative markers implicating oxidative damage on the other biomolecules such as proteins and lipids in patients with COPD who were exposed to smoking and biomass.
MATERIAL AND METHODS: We detected DNA strand breaks in peripheral blood mononuclear leukocytes by using a Single Cell Gel Electrophoresis (also called Comet Assay), plasma protein carbonyl (PC) content by using Reznick and Parker's spectrophotometric method, and lipid peroxidation by measurement of malondialdehyde (MDA) as indexes of oxidative stress in 47 patients with smoking-related COPD and 25 patients with biomass-related COPD and 36 age-and-sex matched control participants.
RESULTS: The mean values of DNA strand breaks, MDA and protein carbonyl levels were significantly higher in smoking- and biomass-related COPD groups than in the control group (ANOVA P<0.001, <0.05 and <0.05, respectively). DNA damage levels were also higher in smoking-related COPD group than in biomass-related COPD group (P<0.05). There was a positive relationship between DNA damage and MDA levels in smoking-related COPD group (P<0.05).
CONCLUSION: Oxidative stress markers and DNA damage were strongly increased in both patient groups with smoking- and biomass-related COPD. However, DNA is more affected in smoking-related COPD patients than in biomass-related COPD. These data indicate that cigarette smoking is a more significant DNA damaging risk factor than biomass smoke.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16307872     DOI: 10.1016/j.rmed.2005.10.011

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  27 in total

Review 1.  Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities.

Authors:  Mathew Suji Eapen; Philip M Hansbro; Anna-Karin Larsson-Callerfelt; Mohit K Jolly; Stephen Myers; Pawan Sharma; Bernadette Jones; Md Atiqur Rahman; James Markos; Collin Chia; Josie Larby; Greg Haug; Ashutosh Hardikar; Heinrich C Weber; George Mabeza; Vinicius Cavalheri; Yet H Khor; Christine F McDonald; Sukhwinder Singh Sohal
Journal:  Drugs       Date:  2018-11       Impact factor: 9.546

2.  Air pollution and circulating biomarkers of oxidative stress.

Authors:  Ralph J Delfino; Norbert Staimer; Nosratola D Vaziri
Journal:  Air Qual Atmos Health       Date:  2011-03-01       Impact factor: 3.763

3.  Indoor black carbon of outdoor origin and oxidative stress biomarkers in patients with chronic obstructive pulmonary disease.

Authors:  Stephanie T Grady; Petros Koutrakis; Jaime E Hart; Brent A Coull; Joel Schwartz; Francine Laden; Junfeng Jim Zhang; Jicheng Gong; Marilyn L Moy; Eric Garshick
Journal:  Environ Int       Date:  2018-03-22       Impact factor: 9.621

Review 4.  Oxidative stress and chromatin remodeling in chronic obstructive pulmonary disease and smoking-related diseases.

Authors:  Isaac K Sundar; Hongwei Yao; Irfan Rahman
Journal:  Antioxid Redox Signal       Date:  2012-11-06       Impact factor: 8.401

5.  Prolidase activity dysregulation and its correlation with oxidative-antioxidative status in chronic obstructive pulmonary disease.

Authors:  Mehmet Gencer; Nurten Aksoy; E Canan Dagli; Elmas Uzer; Sahin Aksoy; Sahbettin Selek; Hakim Celik; Hale Cakir
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

Review 6.  Chronic obstructive pulmonary disease (COPD) and lung cancer: common pathways for pathogenesis.

Authors:  Brielle A Parris; Hannah E O'Farrell; Kwun M Fong; Ian A Yang
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

Review 7.  Role of histone deacetylase 2 in epigenetics and cellular senescence: implications in lung inflammaging and COPD.

Authors:  Hongwei Yao; Irfan Rahman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-07-27       Impact factor: 5.464

Review 8.  Perspectives on translational and therapeutic aspects of SIRT1 in inflammaging and senescence.

Authors:  Hongwei Yao; Irfan Rahman
Journal:  Biochem Pharmacol       Date:  2012-07-14       Impact factor: 5.858

Review 9.  The cGAS-STING pathway: The role of self-DNA sensing in inflammatory lung disease.

Authors:  Ruihua Ma; Tatiana P Ortiz Serrano; Jennifer Davis; Andrew D Prigge; Karen M Ridge
Journal:  FASEB J       Date:  2020-08-28       Impact factor: 5.191

10.  SUL-151 Decreases Airway Neutrophilia as a Prophylactic and Therapeutic Treatment in Mice after Cigarette Smoke Exposure.

Authors:  Lei Wang; Charlotte E Pelgrim; Daniël H Swart; Guido Krenning; Adrianus C van der Graaf; Aletta D Kraneveld; Thea Leusink-Muis; Ingrid van Ark; Johan Garssen; Gert Folkerts; Saskia Braber
Journal:  Int J Mol Sci       Date:  2021-05-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.